{"id":"https://openalex.org/W2165889558","doi":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","title":"Pegylated interferons: chemical and clinical differences","display_name":"Pegylated interferons: chemical and clinical differences","alternate_titles":[],"publication_year":2004,"publication_date":"2004-10-01","ids":{"openalex":"https://openalex.org/W2165889558","doi":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","mag":"2165889558","pmid":"https://pubmed.ncbi.nlm.nih.gov/15479353"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2036.2004.02170.x","doi":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2004.02170.x","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2165889558"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2004.02170.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065033982","display_name":"Graham R. Foster","orcid":"https://orcid.org/0000-0002-3704-386X","observed_orcids":["https://orcid.org/0000-0002-3704-386X"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I2801259928","display_name":"Royal London Hospital","ror":"https://ror.org/019my5047","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044","https://openalex.org/I2801259928"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"G. R. Foster","raw_affiliation_strings":["Hepatobiliary Group, Adult and Pediatric Gastroenterology, Institute of Molecular and Cellular Science, Queen Mary's School of Medicine and Dentistry, Barts and The Royal London Hospital, London, UK. g.r.foster@qmul.ac.uk","Professor of Hepatology, Hepatobiliary Group, Adult and Pediatric Gastroenterology, Institute of Molecular and Cellular Science, Queen Mary's School of Medicine and Dentistry, Barts and The Royal London Hospital, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hepatobiliary Group, Adult and Pediatric Gastroenterology, Institute of Molecular and Cellular Science, Queen Mary's School of Medicine and Dentistry, Barts and The Royal London Hospital, London, UK. g.r.foster@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"]},{"raw_affiliation_string":"Professor of Hepatology, Hepatobiliary Group, Adult and Pediatric Gastroenterology, Institute of Molecular and Cellular Science, Queen Mary's School of Medicine and Dentistry, Barts and The Royal London Hospital, London, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065033982"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I2801259928"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":1.1273,"has_fulltext":true,"cited_by_count":124,"citation_normalized_percentile":{"value":0.72813239,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"20","issue":"8","first_page":"825","last_page":"830"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegylated-interferon","display_name":"pegylated interferon","score":0.8880000114440918},{"id":"https://openalex.org/keywords/peginterferon-alfa-2a","display_name":"peginterferon alfa-2a","score":0.9259999990463257},{"id":"https://openalex.org/keywords/peginterferon-alfa-2b","display_name":"peginterferon alfa-2b","score":1.0},{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9950000047683716},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.7630000114440918},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.996999979019165},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8669999837875366},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dosing-and-administration","display_name":"dosing and administration","score":0.8389999866485596},{"id":"https://openalex.org/keywords/viral-dynamics","display_name":"viral dynamics","score":0.8289999961853027},{"id":"https://openalex.org/keywords/interferon-structure","display_name":"interferon structure","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8703725337982178},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.8698717355728149},{"id":"https://openalex.org/C2776461080","wikidata":"https://www.wikidata.org/wiki/Q7160835","display_name":"Pegylated interferon","level":5,"score":0.7640981674194336},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6679694652557373},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6145195960998535},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6035170555114746},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.5442649722099304},{"id":"https://openalex.org/C2779149719","wikidata":"https://www.wikidata.org/wiki/Q682252","display_name":"PEGylation","level":3,"score":0.5204687118530273},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5090246200561523},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.45024821162223816},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.44028618931770325},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3311619758605957},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2942698299884796},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.23029592633247375},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.1411404311656952},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2036.2004.02170.x","doi":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2004.02170.x","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:15479353","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15479353","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2036.2004.02170.x","doi":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.2004.02170.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2004.02170.x","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2165889558.pdf","grobid_xml":"https://content.openalex.org/works/W2165889558.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W141079205","https://openalex.org/W1987119060","https://openalex.org/W1988527807","https://openalex.org/W2014616917","https://openalex.org/W2017707401","https://openalex.org/W2022098233","https://openalex.org/W2027545435","https://openalex.org/W2027545702","https://openalex.org/W2030616658","https://openalex.org/W2030736973","https://openalex.org/W2043519223","https://openalex.org/W2057689594","https://openalex.org/W2061294380","https://openalex.org/W2065225927","https://openalex.org/W2079771726","https://openalex.org/W2104278356","https://openalex.org/W2112876622","https://openalex.org/W2127685726","https://openalex.org/W2142337801","https://openalex.org/W2144653878","https://openalex.org/W2147523832","https://openalex.org/W2156574153","https://openalex.org/W2165715544","https://openalex.org/W2317554121","https://openalex.org/W2332630894","https://openalex.org/W2336924892"],"related_works":["https://openalex.org/W2046310800","https://openalex.org/W110928060","https://openalex.org/W1902747447","https://openalex.org/W2044771042","https://openalex.org/W2604197648","https://openalex.org/W2059430357","https://openalex.org/W2992833383","https://openalex.org/W2056357109","https://openalex.org/W1993114178","https://openalex.org/W1976527723"],"abstract_inverted_index":{"Pegylated":[0],"interferon":[1],"therapy":[2],"for":[3],"the":[4,72,75,82,90,93,114],"treatment":[5],"of":[6,54,71,92,116],"chronic":[7,122],"hepatitis":[8,123],"C":[9],"virus":[10],"provides":[11],"significant":[12],"increases":[13],"in":[14,32,40,52,119],"sustained":[15,100],"virological":[16,101],"response":[17,38,102],"rates":[18,39,103],"compared":[19],"with":[20,34,121],"standard":[21],"interferons.":[22],"Two":[23],"pegylated":[24,45],"interferons":[25],"are":[26,30,104],"now":[27],"available":[28],"and":[29,48,57,61,64,66,99,106],"used":[31],"conjunction":[33],"ribavirin":[35],"to":[36,80,88,109],"maximize":[37,81],"infected":[41],"patients.":[42],"The":[43],"two":[44,76,94],"interferons,":[46],"peginterferonalpha-2a":[47],"peginterferonalpha-2b,":[49],"differ":[50],"substantially":[51],"terms":[53],"their":[55],"chemical":[56],"structural":[58],"characteristics,":[59],"pharmacokinetic":[60],"pharmacodynamic":[62],"properties,":[63],"dosing":[65],"administration.":[67],"A":[68],"full":[69],"understanding":[70],"differences":[73],"between":[74],"drugs":[77,95],"is":[78],"important":[79],"clinical":[83],"benefits.":[84],"Controlled":[85],"studies":[86],"designed":[87],"characterize":[89],"effects":[91],"on":[96,113],"viral":[97],"kinetics":[98],"emerging":[105],"may":[107],"help":[108],"shed":[110],"additional":[111],"light":[112],"use":[115],"these":[117],"compounds":[118],"patients":[120],"C.":[124]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2165889558","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
